Bhaskar Kallakury Selected Research

Biomarkers (Surrogate Marker)

1/2022	Arginase Pathway Markers of Immune-Microenvironment in Thymic Epithelial Tumors and Small Cell Lung Cancer.
1/2022	AIB1 is a novel target of the high-risk HPV E6 protein and a biomarker of cervical cancer progression.
12/2019	Short- and Long-Term Effects of CDK4/6 Inhibition on Early-Stage Breast Cancer.
4/2019	Prognostic Implications of Arginase and Cytokeratin 19 Expression in Hepatocellular Carcinoma After Curative Hepatectomy: Correlation With Recurrence-Free Survival.
1/2019	African-American Prostate Normal and Cancer Cells for Health Disparities Research.
4/2018	Detection of a lipid peroxidation-induced DNA adduct across liver disease stages.
3/2016	Exemestane Use in Postmenopausal Women at High Risk for Invasive Breast Cancer: Evaluating Biomarkers of Efficacy and Safety.
1/2013	Genome-wide multi-omics profiling of colorectal cancer identifies immune determinants strongly associated with relapse.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bhaskar Kallakury Research Topics

Disease

46	Neoplasms (Cancer) 02/2023 - 02/2006
11	Hepatocellular Carcinoma (Hepatoma) 02/2023 - 01/2013
10	Carcinogenesis 02/2023 - 05/2007
10	Inflammation (Inflammations) 01/2021 - 04/2012
9	Fibrosis (Cirrhosis) 02/2023 - 07/2014
9	Prostatic Neoplasms (Prostate Cancer) 07/2019 - 05/2007
7	Breast Neoplasms (Breast Cancer) 01/2020 - 03/2014
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 12/2018
4	Liver Neoplasms (Liver Cancer) 01/2021 - 05/2011
4	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2014
4	Adenocarcinoma 01/2020 - 06/2009
3	Non-alcoholic Fatty Liver Disease 02/2022 - 01/2020
3	Obesity 01/2020 - 05/2010
2	Carcinoma in Situ 01/2023 - 01/2022
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 01/2011
2	Carcinoma (Carcinomatosis) 01/2022 - 07/2013
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 01/2021
2	Intestinal Volvulus (Volvulus) 01/2021 - 06/2012
2	Liver Diseases (Liver Disease) 01/2021 - 04/2018
2	Wounds and Injuries (Trauma) 10/2015 - 11/2013
2	Ewing Sarcoma (Sarcoma, Ewing) 01/2014 - 11/2011
2	Genetic Translocation (Chromosomal Translocation) 01/2014 - 01/2014
1	Reperfusion Injury 01/2022
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021
1	Intestinal Failure 01/2021
1	Squamous Cell Carcinoma of Head and Neck 01/2020
1	Hyperglycemia 01/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	Pancreatitis 01/2020
1	Glucose Intolerance 01/2020
1	Metaplasia 01/2020
1	Fatty Liver 01/2020

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2007
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2013
5	CytokinesIBA 01/2021 - 05/2002
4	ArginaseIBA 01/2022 - 01/2019
4	DNA (Deoxyribonucleic Acid)IBA 12/2019 - 01/2011
3	Proglumide (Milid)IBA 02/2023 - 01/2020
3	Cholecystokinin Receptors (Cholecystokinin Receptor)IBA 02/2023 - 01/2020
3	rho-Associated KinasesIBA 01/2023 - 02/2012
3	Phenobarbital (Luminal)FDA Link 12/2022 - 01/2019
3	GastrinsIBA 10/2022 - 01/2019
3	SpectrinIBA 01/2021 - 11/2014
3	Cyclin D1IBA 01/2020 - 05/2007
3	Phosphotransferases (Kinase)IBA 01/2020 - 11/2011
3	MicroRNAs (MicroRNA)IBA 01/2019 - 11/2016
3	Calcibiotic Root Canal SealerIBA 01/2017 - 02/2012
2	RNA (Ribonucleic Acid)IBA 02/2023 - 01/2020
2	AntibodiesIBA 02/2023 - 03/2014
2	Estrogens (Estrogen)FDA Link 01/2022 - 01/2011
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
2	Peptides (Polypeptides)IBA 10/2021 - 01/2019
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2021 - 05/2011
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2014
2	LipidsIBA 01/2020 - 07/2014
2	CateninsIBA 12/2019 - 01/2011
2	Estrogen ReceptorsIBA 12/2019 - 07/2013
2	Keratin-19 (Keratin 19)IBA 10/2019 - 04/2019
2	Protein Kinases (Protein Kinase)IBA 01/2019 - 12/2018
2	Messenger RNA (mRNA)IBA 01/2019 - 01/2014
2	LigandsIBA 01/2019 - 07/2013
2	ParaffinIBA 01/2019 - 04/2018
2	Monoclonal AntibodiesIBA 04/2018 - 01/2018
2	IonsIBA 02/2014 - 08/2010
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2014 - 05/2007
2	AndrogensIBA 01/2014 - 04/2009
2	probasinIBA 06/2009 - 05/2007
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2007 - 05/2002
1	BuffersIBA 02/2023
1	Phosphates (Orthophosphate)IBA 02/2023
1	Programmed Cell Death 1 ReceptorIBA 02/2023
1	Cholecystokinin B ReceptorIBA 01/2023
1	bicalutamide (Casodex)FDA LinkGeneric 12/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2022
1	niraparibIBA 12/2022
1	Androgen Antagonists (Antiandrogens)IBA 12/2022
1	olaparibIBA 12/2022
1	Proton Pump InhibitorsIBA 10/2022
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2022
1	Angiotensin IIIBA 01/2021
1	Versicans (Versican)IBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	PlatinumIBA 01/2021
1	Choline (Choline Chloride)IBA 01/2020
1	Cadherins (E-Cadherin)IBA 01/2020
1	CeruletideIBA 01/2020
1	citrate-binding transport proteinIBA 01/2020
1	Lipase (Acid Lipase)FDA Link 01/2020
1	Protons (Proton)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Transaminases (Aminotransferases)IBA 01/2020
1	EthionineIBA 01/2020

Therapy/Procedure

16	Therapeutics 01/2023 - 05/2007
8	Transplantation 01/2021 - 12/2007
3	Prostatectomy (Retropubic Prostatectomy) 12/2022 - 07/2014
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2018
2	Parenteral Nutrition 01/2021 - 07/2014
2	Colectomy 08/2019 - 06/2012
2	Liver Transplantation 07/2019 - 06/2016
1	Total Parenteral Nutrition 01/2021